3rd International Conference on

Dementia and Dementia Care

Dementia 2022

Theme: Exploring Advances in the field of Dementia Research

We welcome all the enthusiastic researchers from all around the world to join us for the “3rd International Conference on Dementia and Dementia Care” scheduled in Dubai, UAE during March 25-26, 2022. The summit will move forward with the theme “Exploring Advances in the field of Dementia Research”. This Dementia conference is a global platform for professors, deans, academic researchers, industrialists, nutritionists’ dieticians, doctors, young scientists, students, delegates, and health professionals. Dementia Conference is comprised to offer comprehensive sessions that address current issues in the field of NeuroScience. 
Dementia Conference can target the foremost recent and energizing developments in each facet of insanity think about that offers a noteworthy open door for agents over the world to fulfill, organize, and see new logical advancements. The two days gathering incorporates symposiums and exceptional keynote sessions by notable and eminent speakers who exceed expectations within the field of insanity.

Dementia Care Management
 
Caring for a person with dementia influences distinctive people in diverse ways. In any case, caring can also be both physically and rationally debilitating. It affects all factors of your life and may have an impact on you to feel separated, driven and at instances even discouraged. You may additionally have your own physical and psychological wellbeing needs, which you and others may additionally neglect while you are tending to some other person. There are severe high-quality things about caring. 
 
 
Vascular Dementia
 
Early stage vascular dementia slightly resembles Alzheimer’s, although instead of being primarily characterized by forgetfulness, it is more associated with difficulty planning, decision-making, and following steps. Other early symptoms include slower speed of thought, difficulty maintaining focus, and increased likelihood of experiencing anxiety, depression, and mood swings. Following one or more strokes, Vascular dementia may also include physical symptoms such as vision or speech problems and weakness in limbs, although these symptoms might show improvement with rehabilitation.
 
 
Mild Cognitive Impairment (MCI)
 
Mild cognitive impairment (MCI) is a condition in which someone has minor problems with cognition - their mental abilities such as memory or thinking. In MCI these difficulties are worse than would normally be expected for a healthy person of their age. However, the symptoms are not severe enough to interfere significantly with daily life, and so are not defined as dementia.
It is estimated that between 5 and 20% of people aged over 65 have MCI. It is not a type of dementia, but a person with MCI is more likely to go on to develop dementia. This page explains what MCI is, the link between MCI and dementia, and the benefits of diagnosing MCI. It then looks at treatments for MCI, ways to cope with the symptoms, and how you can reduce your risk of developing MCI and dementia. Many people who are diagnosed with MCI use this as an opportunity to change their lifestyle for the better. There is a lot that someone can do to help reduce their chances of MCI progressing to dementia.
 
 
Dementia with Lewy Bodies (LBD)
 
Lewy  body of dementia can also look a little like Alzheimer’s in the early stage, although there are some key differences. In the early stage of Dementia with Lewy bodies (LBD), the individual’s attention and awareness can fluctuate greatly from day to day, or even from moment to moment. Many also have recurrent visual hallucinations that they are able to describe in vivid detail, and some have auditory hallucinations as well. Sometimes these can lead to faulty perceptions and delusions of persecution.
 
 
Huntington's Disease
 
A defect in a single gene causes Huntington’s disease. It’s considered an autosomal dominant disorder. This means that one copy of the abnormal gene is enough to cause the disease. If one of your parents has this genetic defect, you have a 50 percent chance of inheriting it. You can also pass it on to your children.
The genetic mutation responsible for Huntington’s disease is different from many other mutations. There isn’t a substitution or a missing section in the gene. Instead, there is a copying error. An area within the gene is copied too many times. The number of repeated copies tends to increase with each generation.
 
 
Alzheimer’s Disease
 
Dementia is the term applied to a group of symptoms that negatively impact memory, but Alzheimer’s is a progressive disease of the brain that slowly causes impairment in memory and cognitive function. The exact cause is unknown and no cure is available.
The National Institute of health estimate that more than 5 million people in the United States have Alzheimer’s disease. Although younger people can and do get Alzheimer’s, the symptoms generally begin after age 60.
The time from diagnosis to death can be as little as three years in people over 80 years old. However, it can be much longer for younger people.
 
 
Parkinson’s  Disease
 
Parkinson-type motor skills problems (e.g. slowness, stiffness, tremors) are also common in people with dementia with Lewy Bodies (LBD) and are often present at the time of diagnosis.
 
 
Semantic Dementia
 
Semantic dementia refers to a progressive loss of the ability to remember the meaning of words, faces and objects, which results from shrinkage of the temporal lobes of the brain. However, there is wide variation in the speed of progression.  Some people show little decline over the course of a year whereas others change more quickly.  Usually, monitoring a person’s progress over a year will give a good guide as to the likely future rate of progression.
 
 
Frontotemporal Dementia
 
The early stage of Frontotemporal dementia has different symptoms as memory and cognitive functioning are relatively spared. Behavioral variant frontotemporal dementia (bvFTD) primarily influences individuals’ behaviors and emotions. Common behavioral changes include becoming uncharacteristically selfish, apathetic, and uninhibited. Over-eating can also be a problem.
Individuals with bvFTD might act impulsively and inappropriately in social situations, disregarding manners. There are two other less common forms of frontotemporal dementia with different initial symptoms. Semantic dementia primarily affects ability to recall names and understand language, and progressive non-fluent aphasia affects individuals’ abilities to produce fluent speech.
 
 
Dementia Nursing
 
People with vascular dementia have distinct mental element shortfalls that incorporate each reminiscence hindrance, that impacts the adaptability to find out new statistics or review facts already learned, and one or greater of the ensuing aspect outcomes aphasia, apraxia, agonise, or reputable brokenness to such an extent that the mental detail shortages adversely affect social or action working with a chief decrease in beyond abilities. Furthermore, human beings with dementia commonly enjoy the ill consequences of comorbid situations that more confuse thoughts and block best results. 
 
 
Dementia Treatment
 
In some cases, treating the condition that causes dementia may help. Conditions most likely to respond to treatment include dementia due to:
• drugs
• tumors
• metabolic disorders
• hypoglycerni
In most cases, dementia isn’t reversible. However, many forms are treatable. The right medication can help manage dementia. Treatments for dementia will depend on the cause.
 
 
Bioinformatics Approach for Dementia
 
Bioinformatics advent can be used to regulate and evaluate datafrom the current high-throughput research technologies and render means fornovel discoveries in the field of neurodegenerative diseases. It is reported that there is a very little published data onEpigenomics. It is said that the data are obtained from high through puttechnologies in screening of human brain. These data intend the upcoming researchers to know and designtheir experiments. The Data Mining plays an important role in the prediction ofthe disorder, where the actual data is compared with the real data and theresults are interpreted. The Transcriptomics and Proteomics studies has alsobeen carried out providing necessary solutions for the problems.
 

 

Dementia Drugs Market is valued at USD 15535.2 Million in 2018 and expected to reach USD 32662.5 Million by 2025 with the CAGR of 11.20% over the forecast period. Dementia is a syndrome of loss of cognitive functioning such as; thinking, remembering, and reasoning and behavioral abilities to such an extent that it interferes with a person’s daily life and activities. It occurs when the parts of the brain used for learning, memory, decision making and language are damaged or diseased. It has major impact on memory, thinking, orientation, comprehension calculation, learning capacity, language and judgment. But the consciousness is not affected. It is one of the major reason of disability and dependency of older people globally. In older population, Alzheimer’s disease is the most common cause of a progressive dementia but there are various other factors also which causes the dementia. Depending on the cause, some of the dementia cases may be reversible majorly affects people of aged 65 years and above. Currently, there is no curative therapy available for dementia disease. However, drugs for dementia therapy are in pipeline, which are expected to be launched in the near future, in turn propelling growth of the dementia drugs market.
 
Key Benefits for Dementia Drugs Market Report: 
• Global market report covers in depth historical and forecast analysis.
• Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global market report helps to identify opportunities in market place.
• Global market report covers extensive analysis of emerging trends and competitive landscape.
 
Global Universities:
  1. University of Salford
  2. University of Bradford
  3. University of Cardiff
  4. University of Nottingham
  5. University of Sheffield
  6. Loughborough University
  7. University of Worcester
  8. University college London
  9. Leeds Beckett University
  10. Lancaster University
  11. Bangor  University
Research Centers of Dementia:
1. Alzheimer’s Drug Discovery Foundation.
2. The Alzheimer’s Foundation of America.
3. The Alzheimer’s Association International Research Grant Program.
4. Banner Alzheimer’s Initiative.
5. Coins for Alzheimer’s Research.
6. Cure Alzheimer’s FundAlzheimer’s Society (UK).
7. Fisher Center for Alzheimer’s Research.
8. Geoffrey Beene Foundation Alzheimer’s Initiative.
9. National Alzheimer’s Coordinating Center (NACC).
10. National Cell Repository for Alzheimer’s Disease (NCRAD).
11. John’s Hopkins School of Medicine Alzheimer’s Disease Research Center.
12. Mayo Clinical Alzheimer’s Disease Research Center.
13. University of Pennsylvania Alzheimer’s Disease Center.
14. Yale University Alzheimer’s Disease Research Unit.
15. Mount Sinai School of Medicine Alzheimer’s Disease Research Center.
16. University of Kansas Alzheimer’s Disease Center.
17. The Taub Institute for Research on Alzheimer’s Disease.
18. University of Wisconsin Alzheimer’s Disease Center.
19. Boston University Alzheimer’s Disease Center.
20. Arizona Alzheimer’s Disease Center/Sun Health Research Institute.
21. Oregon Health and Science University Aging and Alzheimer’s Disease Center.
22. Alzheimer’s Disease Research Center University of California.
23. Washington University at St. Louis. Alzheimer’s Disease Research Center.
24. University of Washington Alzheimer’s Research Center.
25. Emory University Alzheimer’s Disease Center.
26. University of Pittsburgh Alzheimer’s Disease Research.
27. New York University Center of Excellence on Brain Aging.
28. Harvard Medical School Alzheimer’s Disease Research Center.
29. Indiana University Alzheimer Disease Center
30. Rush University Medical Center Alzheimer’s Disease Center
31. University of California – Davis, Alzheimer’s Disease Center.
32. University of Kentucky Alzheimer’s Disease Center.
 
 
Future Scope:
 
The Annals of Alzheimer's and Dementia Care is a one of the peer reviewed, international and distinguished journal, which covers the outstanding and most update research works peak quality papers. It provides consistent information to update online viewers with the adapted methods and latest advancements in the field of Alzheimer's and Dementia Care. All contributions shall be rigorously refereed and selecting on the basis of quality and originality of the work as well as the breadth of interest to readers.
 
This clinical journal which publishes comprehensive reviews, research articles, short reports, information on clinical trials, media reviews, open-peer commentaries or in-depth perspectives, translational and/or theoretical papers that attempt integrate knowledge across discipline, politics & history of science/brief biographies, abstracts of papers presented at international meetings, and negative results, particularly clinical trials, as short communications in the results of studies in behavior management, brain research, genetics, psychiatry, molecular biology, pharmacology, sociology, protein chemistry, physiology, neuropathology, neurology, biochemistry, geriatrics, neuropsychology, epidemiology, health services research, political science, health economics, caregiving, communication strategies, evaluation, heredity, long-term care, memory loss, pharmacotherapy, psychosocial issues, recreation and activity therapy, restraint-free care, special care units, symptom management, and public policy. Content emphasizes interdisciplinary investigations, integrative/translational articles, related to: risk factors, early detection, etiology, and disease modifying interventions, prevention of dementia and applications of new technologies in health services.
 
It includes information on management of concurrent medical issues in the patient with dementia, New and forthcoming diagnostic tools such as computerized testing for mild cognitive impairment and other aspects of cognitive testing, as well as high technology resources for sophisticated disease characterization. It also provides information on the clinical features and management of non-Alzheimer's dementias. 
Meetings International has taken an initiative to congratulate attendees with awards to recognise, celebrate and encourage action in its varied conferences and events. We have a tendency to salute and acknowledge attainment among business that's persistently evolving and re-drawing the boundaries of best follow. These awards represent the top of skilled action for event professionals. To win a present you'll are supported by our illustrious panel of the foremost business professionals that could be a successful form of your formidable credentials.
 
Best Speaker in Dementia 2022: This award identifies educational and business speakers for his or her wonderful presentation skills and for the numerous contribution that they create to their professions, their groups and their patients through their follow, leadership or analysis endeavour. Recipient of this award are chosen by the session chair and co-chair. The awardee are felicitated when the completion of oral session. Our   encourage researchers from across the world to require half as a speaker at these prestigious events.
Best Key Note Speaker in Dementia 2022: This award recognises the notable shows given throughout the course of the event. It additionally acknowledges the keenness and determination of the speaker to enhance the expertise of all World Health Organization they are available into contact with. The award are given supported the impact of presentation on the attendees of the event. We'll even be taking under consideration the references taken from the citations of the keynote speaker. These awards are felicitated by one in all the members of the organizing panel gift throughout the conference.
Best Organising member in Dementia 2022: This award pursues to recognise the continual support provided by the Organising member of this prestigious conference. Recipient of this award are designated by the operative committee of the event. The award are given supported the support and cooperation provided by a member of the organizing panel from the start to the roaring completion of the conference.
Outstanding Young Scientists Award in Dementia 2022: This award seeks to recognise the young brains of this era. Recipient of this award are designated by choosing the Young Researchers Forum. This award are given supported the presentation skills, impact of analysis and its applications for the Nephrologists Conference 2022. Participants following Masters, Doctor of Philosophy or Post-Doctoral studies are eligible for this award. The awards are felicitated when the completion of all the oral shows delivered below the Young Researchers Forum class.
 
Best Poster Award in Dementia 2022:  This award recognises the most effective poster presentation given throughout the course of an occurrence. Recipient of this award are designated by choosing the poster session. a present winning poster are evaluated on presentation content and clarity, originality of approach, communication criteria and scientific aspects. It'll even be supported layout, insights, analysis and results description. The awardee are felicitated when the completion of poster session.
The awards given for our aid conferences recognise the big selection of responsibilities and dedication of Nephrologists and Cardiologists World Health Organization promote the very best standards of care across the complete health service. Nephrologists Conference 2022 event create a large contribution to maintaining and protective the health and well-being of individuals across the world.

 

  • Dementia Care Management
  • Vascular Dementia
  • Mild Cognitive Impairment (MCI)
  • Dementia with Lewy Bodies (LBD)
  • Huntington's Disease
  • Alzheimer's Disease
  • Parkinson's Disease
  • Semantic Dementia
  • Frontotemporal Dementia
  • Dementia Nursing
  • Dementia Treatment
  • Bioinformatics Approach for Dementia

1 Organizing Committee Members

OCM Member
Dr. Alain L. Fymat

Institute Professor, International Institute of Medicine and Science
Rancho Mirage, California, U.S.A.
United States

More...

2 Renowned Speakers

Karl Sterling

Neuro-rehabilitation Specialist
United States of America

Bajrangi Yadav

Kamla Nehru Institute
India